Related references
Note: Only part of the references are listed.The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19
Juan Gomez et al.
CYTOKINE (2021)
Opposing activities of IFITM proteins in SARS-CoV-2 infection
Guoli Shi et al.
EMBO JOURNAL (2021)
Potential role of interferons in treating COVID-19 patients
Mohadeseh Haji Abdolvahab et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells
Mahmood Yaseen Hachim et al.
FRONTIERS IN IMMUNOLOGY (2020)
Inhibition of SARS-CoV-2 by type I and type III interferons
Ulrike Felgenhauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
Zhe Liu et al.
JOURNAL OF VIROLOGY (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
Antoni G. Wrobel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Syncytia formation by SARS-CoV-2-infected cells
Julian Buchrieser et al.
EMBO JOURNAL (2020)
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Achille Broggi et al.
SCIENCE (2020)
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
Megan L. Stanifer et al.
CELL REPORTS (2020)
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Andrew D. Davidson et al.
GENOME MEDICINE (2020)
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Kumari G. Lokugamage et al.
JOURNAL OF VIROLOGY (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans
Rayhane Nchioua et al.
MBIO (2020)
Evasion of Type I Interferon by SARS-CoV-2
Hongjie Xia et al.
CELL REPORTS (2020)
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
Tongqing Zhou et al.
CELL HOST & MICROBE (2020)
Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state
Kazi Rahman et al.
ELIFE (2020)
Interferon-Stimulated Genes: What Do They All Do?
John W. Schoggins
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections
Xuesen Zhao et al.
FRONTIERS IN MICROBIOLOGY (2019)
Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane
Toshana L. Foster et al.
FRONTIERS IN IMMUNOLOGY (2018)
pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs
Thomas Gerlach et al.
JOURNAL OF VIROLOGY (2017)
More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins
Guoli Shi et al.
RETROVIROLOGY (2017)
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
Toshana L. Foster et al.
Cell Host & Microbe (2016)
HIV-1 and interferons: who's interfering with whom?
Tomas Doyle et al.
NATURE REVIEWS MICROBIOLOGY (2015)
An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
K. Grehan et al.
METHODSX (2015)
Identification of an endocytic signal essential for the antiviral action of IFITM3
Rui Jia et al.
CELLULAR MICROBIOLOGY (2014)
Phosphorylation of the Antiviral Protein Interferon-inducible Transmembrane Protein 3 ( IFITM3) Dually Regulates Its Endocytosis and Ubiquitination
Nicholas M. Chesarino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
Charles C. Bailey et al.
ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)
Highly Sensitive Real-Time In Vivo Imaging of an Influenza Reporter Virus Reveals Dynamics of Replication and Spread
Vy Tran et al.
JOURNAL OF VIROLOGY (2013)
S-Palmitoylation and Ubiquitination Differentially Regulate Interferon-induced Transmembrane Protein 3 (IFITM3)-mediated Resistance to Influenza Virus
Jacob S. Yount et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Evolutionary Dynamics of the Interferon-Induced Transmembrane Gene Family in Vertebrates
Zhao Zhang et al.
PLOS ONE (2012)
IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
Eric M. Feeley et al.
PLOS PATHOGENS (2011)
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
I-Chueh Huang et al.
PLOS PATHOGENS (2011)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
Share Paper
